Latest News
Pharming secures FDA acceptance of Joenja filing for children with APDS
4 June 2026 - Biopharmaceutical company Pharming Group N.V. (Euronext Amsterdam:PHARM) (NASDAQ:PHAR) announced on Thursday that the US Food and Drug Administration (FDA) has accepted the resubmitted supplemental New Drug Application for Joenja (lenio...
UCB and Biogen present Phase 3 data highlighting potential of dapirolizumab pegol in lupus treatment
4 June 2026 - Global biopharmaceutical company UCB (Euronext Brussels:UCB) and US biotechnology company Biogen Inc (NASDAQ:BIIB) on Thursday announced data demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic, ...
Persist AI partners with Microsize and Micromacinazione to launch drug formulation platform
4 June 2026 - Persist AI, an AI and robotics-powered pharmaceutical formulation research company, announced on Wednesday that it has formed a strategic collaboration with pharmaceutical micronization specialists Microsize and Micromacinazione (Micmac...
RedHill Biopharma advancing opaganib options for Ebola outbreak
4 June 2026 - Specialty biopharmaceutical company RedHill Biopharma Ltd (Nasdaq:RDHL) announced on Wednesday that it is actively discussing potential collaborations for advancement of its investigational oral drug, opaganib, to combat Ebola virus dis...
Sun Pharma receives American Skin Association 2026 Corporate Leadership Award
4 June 2026 - American Skin Association (ASA) announced on Wednesday that India-based pharmaceutical company Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA, BSE: 524715) has received its 2026 Corporate Leadership Award.Howard P. Milstein, ASA ...